Synageva BioPharma Corp (NASDAQ:GEVA)

102.82
BATS BZX Real-Time Price
As of 11:04am ET
 +3.40 / +3.42%
Today’s Change
60.19
Today|||52-Week Range
122.88
+10.81%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Synageva BioPharma Corp have a median target of 115.50, with a high estimate of 125.00 and a low estimate of 111.00. The median estimate represents a +12.33% increase from the last price of 102.82.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Synageva BioPharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.71
Sales
$1.4M
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -17.21%
 
 
 
 
 
 
Growthannually -72.28%
 
 
 
 
 
 

Sales

Growthquarterly 1.99%
 
 
 
 
 
 
Growthannually -50.04%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account